Levoquin: Potent Antibiotic for Severe Bacterial Infections
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.46 | $43.86 (0%) | 🛒 Add to cart |
| 60 | $1.29 | $87.72 $77.40 (12%) | 🛒 Add to cart |
| 90 | $1.12 | $131.58 $100.62 (24%) | 🛒 Add to cart |
| 120 | $0.99 | $175.44 $118.68 (32%) | 🛒 Add to cart |
| 180 | $0.86 | $263.16 $154.80 (41%) | 🛒 Add to cart |
| 270 | $0.77 | $394.74 $208.98 (47%) | 🛒 Add to cart |
| 360 | $0.75
Best per pill | $526.32 $269.18 (49%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $1.72 | $34.40 (0%) | 🛒 Add to cart |
| 30 | $1.63 | $51.60 $49.02 (5%) | 🛒 Add to cart |
| 60 | $1.55 | $103.20 $92.88 (10%) | 🛒 Add to cart |
| 90 | $1.41 | $154.80 $127.28 (18%) | 🛒 Add to cart |
| 120 | $1.29 | $206.40 $154.80 (25%) | 🛒 Add to cart |
| 180 | $1.07 | $309.60 $193.50 (38%) | 🛒 Add to cart |
| 270 | $0.97 | $464.40 $262.30 (44%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $619.20 $318.20 (49%) | 🛒 Add to cart |
Levoquin (levofloxacin) is a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of adults with serious bacterial infections. As the optically active L-isomer of ofloxacin, it demonstrates enhanced antibacterial activity with an improved pharmacokinetic profile. This prescription medication targets a wide range of Gram-positive and Gram-negative pathogens, including those resistant to other antibiotic classes. Clinical evidence supports its efficacy in combating complicated infections across multiple organ systems when other treatments have proven inadequate or inappropriate.
Features
- Contains levofloxacin as the active pharmaceutical ingredient
- Available in oral tablets (250 mg, 500 mg, 750 mg) and injection formulations
- Broad-spectrum activity against aerobic Gram-positive and Gram-negative bacteria
- Excellent tissue penetration with high bioavailability (>99%)
- Convenient once-daily dosing regimen
- Demonstrated stability across various pH conditions
Benefits
- Effectively treats severe and complicated bacterial infections when first-line antibiotics fail
- Rapid bactericidal action minimizes bacterial load and reduces infection severity
- Comprehensive coverage reduces the need for combination antibiotic therapy
- Once-daily dosing improves patient compliance and treatment adherence
- Proven efficacy in both hospital and community-acquired infections
- Well-established safety profile with extensive clinical documentation
Common use
Levoquin is prescribed for the treatment of adults with complicated urinary tract infections, including pyelonephritis. It is indicated for community-acquired pneumonia of mild to moderate severity, acute bacterial sinusitis, chronic bacterial prostatitis, complicated skin and skin structure infections, and nosocomial pneumonia. Additionally, it may be used for inhalational anthrax exposure and plague. Healthcare providers prescribe Levoquin when the benefits outweigh potential risks, particularly for infections caused by susceptible strains of designated microorganisms.
Dosage and direction
The dosage of Levoquin varies according to the type and severity of infection, renal function, and the pathogen involved. For most indications, the recommended dose is 250-750 mg administered orally or intravenously once every 24 hours. The duration of treatment typically ranges from 7 to 14 days, depending on the infection site and clinical response. Patients with impaired renal function require dosage adjustment based on creatinine clearance. Tablets should be swallowed whole with a full glass of water, with or without food, at approximately the same time each day. Complete the full course of therapy even if symptoms improve earlier.
Precautions
Patients should be advised that Levoquin may cause dizziness and lightheadedness; therefore, caution is recommended when operating machinery or driving. Adequate hydration should be maintained to prevent crystal formation in urine. Exposure to direct sunlight or artificial UV light should be minimized due to photosensitivity reactions. Tendon inflammation or rupture may occur during or after treatment, particularly in elderly patients and those receiving corticosteroid therapy. Blood glucose disturbances have been reported, requiring monitoring in diabetic patients.
Contraindications
Levoquin is contraindicated in patients with known hypersensitivity to levofloxacin, other quinolone antibiotics, or any component of the formulation. Its use is prohibited in patients with a history of tendon disorders related to fluoroquinolone administration. Concomitant administration with tizanidine is contraindicated due to potentially serious drug interactions. The medication should not be used in patients with known QTc prolongation or uncorrected hypokalemia.
Possible side effects
Common adverse reactions include nausea (3-7%), diarrhea (1-5%), headache (3-6%), constipation (1-3%), and dizziness (1-3%). Less frequently, patients may experience insomnia, abdominal pain, or dyspepsia. Serious side effects requiring immediate medical attention include tendon pain or rupture, peripheral neuropathy, central nervous system effects (seizures, increased intracranial pressure), and exacerbation of myasthenia gravis. Clostridium difficile-associated diarrhea may range from mild to life-threatening.
Drug interaction
Levoquin may interact with antacids containing magnesium or aluminum, sucralfate, metal cations such as iron, and multivitamins containing zinc, reducing absorption significantly (separate administration by at least 2 hours before or 4 hours after). Concurrent use with nonsteroidal anti-inflammatory drugs may increase the risk of CNS stimulation and seizures. It may enhance the effects of warfarin, requiring increased INR monitoring. QTc prolongation may be exacerbated when administered with other drugs that prolong the QTc interval. Theophylline levels should be monitored when co-administered.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed administration. Maintaining consistent blood levels is important for therapeutic efficacy, but occasional missed doses are unlikely to significantly impact overall treatment outcomes if the regular schedule is promptly resumed.
Overdose
In case of overdose, symptomatic and supportive care should be instituted. ECG monitoring is recommended due to the potential for QTc prolongation. Hemodialysis removes approximately 10% of the administered dose and may be considered in cases of severe overdose. There is no specific antidote for levofloxacin overdose. Management should include gastric lavage if ingestion occurred within one hour, followed by appropriate symptomatic treatment. Seizure activity should be managed with standard anticonvulsant therapy.
Storage
Store Levoquin tablets at room temperature (15-30°C or 59-86°F) in their original container, protected from light and moisture. Keep the medication out of reach of children and pets. Do not store in bathroom cabinets where humidity levels may fluctuate. Discard any unused medication after completing the prescribed course of treatment or after the expiration date printed on the packaging. Do not flush medications down the toilet or pour them into drains unless specifically instructed to do so.
Disclaimer
This information does not replace professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions. Do not disregard professional medical advice or delay seeking it because of information contained herein. The prescribing information provided may not include all possible uses, directions, precautions, or interactions.
Reviews
Clinical studies demonstrate Levoquin’s efficacy with clinical success rates of 85-95% across various infection types. Healthcare professionals report satisfactory outcomes in complicated infections, particularly noting its value in cases involving resistant pathogens. Some clinicians express concern regarding potential adverse effects, leading to careful patient selection. Patient reviews frequently mention rapid symptom improvement but also report gastrointestinal side effects as the most common treatment-emergent issue. The once-daily dosing regimen receives positive feedback for convenience and adherence support.